Americas obesity epidemic does not seem to be fading, either, with obesity prevalence in the U.S
Adems de lo esencial, muchos usuarios valoran la personalizacin: cuotas resaltadas segn preferencias, recordatorios de eventos clave, reseas de juegos y recomendaciones basadas en historial
Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
While GLP-1s are becoming popular, success depends on more than just the prescription